For example, tumor necrosis factor (TNF)-α inhibitors may lead to tuberculosis reactivation, and anti-CD20 targeted therapy may lead to hepatitis B virus (HBV) reactivation [6,7,8,9]. Here, TNF is linked to tuberculosis.